Wu Zhong
Vincenzo Brancaleone
Janet Sultana
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, China
- 2Department of Science, University of Basilicata, Potenza, Italy
- 3College of Medicine and Health, University of Exeter, Exeter, United Kingdom
A Corrigendum on:
Editorial: The mechanisms of action of anti-SARS-CoV-2 drugs
by Zhong W, Brancaleone V, Sultana J (2022). Front. Pharmacol. 13:894310. doi: 10.3389/fphar.2022.894310
Authors “Vincenzo Brancaleone and Janet Sultana” were not included as authors in the published article.
The corrected Author Contributions Statement appears below.
“WZ completed the draft manuscript, VB and JS contributed to the drafting of the paper and approved the final version.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: SARS-CoV-2, drug repurposing, mechanism of action, small-molecule drug, Target-based drug design
Citation: Zhong W, Brancaleone V and Sultana J (2022) Corrigendum: Editorial: The mechanisms of action of anti-SARS-CoV-2 drugs. Front. Pharmacol. 13:1065930. doi: 10.3389/fphar.2022.1065930
Received: 10 October 2022; Accepted: 11 October 2022;
Published: 07 November 2022.
Approved by:
Frontiers in Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Zhong, Brancaleone and Sultana. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Wu Zhong, emhvbmd3dUBibWkuYWMuY24=